1 / 3

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/left ventricular dysfunction in the SHIFT trial. Borer JS, et al. Am J Cardiol . 2013. 2014;113(3):497-503.

neola
Télécharger la présentation

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Systolic Heart failure treatment withthe Ifinhibitor ivabradineTrial Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/left ventricular dysfunction in the SHIFT trial Borer JS, et al. Am J Cardiol. 2013. 2014;113(3):497-503 www.shift-study.com

  2. Efficacy of ivabradine in patients according to heart failure severity Ivabradine can be safely used in severe heart failure, and may improve clinical outcomes, independently of disease severity Borer JS, et al. Am J Cardiol. 2013. 2014;113(3):497-503 www.shift-study.com

  3. Efficacy of ivabradine in patients according to heart failure severity Borer JS, et al. Am J Cardiol. 2013. 2014;113(3):497-503 www.shift-study.com

More Related